Daya Medicals, Inc. – Trademark Portfolio

Entity Type: 03

Daya Medicals, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MEDPOD. The owner is based in West Palm Beach, FL.

610 Clematis Street, Unit 318

West Palm Beach, FL 33401

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MEDPOD
MEDPOD
Registered 2010
CARVASIN
CARVASIN
Cancelled 2010

Trademark Classifications

Daya Medicals, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Daya Medicals, Inc. have?

Daya Medicals, Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.

What trademark classes does Daya Medicals, Inc. file in?

Daya Medicals, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Daya Medicals, Inc.'s most well-known trademarks?

Daya Medicals, Inc.'s registered trademark portfolio includes well-known marks such as MEDPOD. These are among 1 currently registered trademark in the portfolio.

What is Daya Medicals, Inc.'s trademark registration success rate?

Daya Medicals, Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.